Workflow
A+H双上市格局
icon
Search documents
美妆巨头贡献超14%营收,天下秀冲刺港股IPO
Sou Hu Cai Jing· 2026-01-16 03:11
作者:园园 作为红人服务机构,天下秀服务于众多美妆行业客户,涵盖宝洁、欧莱雅、联合利华、雅诗兰黛等知名 品牌客户。招股书显示,截至2025年9月30日,欧莱雅(中国)有限公司与雅诗兰黛(上海)商贸有限 公司分别位列天下秀前五大客户的第二、三位,2025年前三个季度分别贡献销售额1.95亿元和1.92亿 元,合计贡献集团收入的14.1%,成为公司最稳定的收入来源之一。 | 截至2025年 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 9月30日止 | | | | | | | 佔本集團 | | 九個月的 | 業務開係 | | | 所提供 | | | 收入總額 | | 五大客戶 | 開始年度 | 公司背景 | 總部所在地 | 主要服務 信貸期 | 付款方式 | 交易金額 | 百分比 | | | | | | | | 人民幣于元 | % | | 客戶B | 2018年 | 全球領先的 | 中國深圳 | 紅人營銷解決方案 30天 | 電圧 | 613.159 | 22.4 | | | | 信息通信 | | 服務 | | | | | ...
A股市场涌现赴港上市浪潮,众多头部企业纷纷构建“A+H”双上市格局。
Sou Hu Cai Jing· 2025-05-30 09:56
Group 1: Recent IPOs - Jihong Co., a cross-border social e-commerce and paper packaging solutions provider, successfully listed on the Hong Kong Stock Exchange, raising approximately HKD 522 million with a market capitalization of HKD 4.4 billion [1] - Paige Bio, a biotechnology company focused on innovative therapies for chronic diseases, also listed on the Hong Kong Stock Exchange, raising around HKD 301 million with a market cap of HKD 3.991 billion [2] - Shouhui Technology, an online insurance intermediary service provider, listed on the Hong Kong Stock Exchange, raising HKD 197 million with a market cap of HKD 1.551 billion [3] Group 2: Upcoming IPOs - Excellence Homeopathy submitted an IPO application to the SEC for a Nasdaq listing, planning to issue 1.3 million shares and raise approximately USD 6 million [4] - DeepGreenX, an AI green energy data service provider, filed for a Nasdaq IPO, focusing on the interconnectivity of data, energy, and real-world assets [5] - Aibol Green, a recycling platform, submitted an IPO application to the SEC for a Nasdaq listing, focusing on the recycling of black metals and household appliances [6] Group 3: Companies in the Pipeline - Huaxida, an AI home solutions provider, submitted an IPO application to the Hong Kong Stock Exchange, aiming to be a leading provider in the AI home solutions market [7] - Kewang Pharmaceutical, a biopharmaceutical company, refiled for an IPO on the Hong Kong Stock Exchange, focusing on innovative cancer treatments [8] - Furuitech, an intelligent driving solutions provider, resubmitted its IPO application to the Hong Kong Stock Exchange, focusing on advanced driving assistance systems [9] Group 4: Market Trends - The A-share market is experiencing a surge in companies planning to list in Hong Kong, with notable interest from leading firms like CATL and BYD, as H-shares outperform A-shares [29] - Shein, a global fast-fashion giant, plans to submit a listing application in Hong Kong after facing challenges in London, aiming for a valuation exceeding USD 100 billion [30]